Iophen-C NR Interactions
There are 507 drugs known to interact with Iophen-C NR (codeine/guaifenesin), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 123 are major, 381 are moderate, and 3 are minor.
- View all 507 medications that may interact with Iophen-C NR
- View Iophen-C NR alcohol/food interactions (1)
- View Iophen-C NR disease interactions (16)
Most frequently checked interactions
View interaction reports for Iophen-C NR (codeine / guaifenesin) and the medicines listed below.
- acetaminophen / hydrocodone
- alprazolam
- amlodipine
- atorvastatin
- azithromycin
- benzonatate
- bupropion
- cyanocobalamin
- cyclobenzaprine
- doxycycline
- fluticasone nasal
- gabapentin
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- metformin
- methylprednisolone
- omeprazole
- ondansetron
- potassium chloride
- prednisone
- ProAir HFA (albuterol)
- ranitidine
- simvastatin
- Singulair (montelukast)
- sumatriptan
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Iophen-C NR alcohol/food interactions
There is 1 alcohol/food interaction with Iophen-C NR (codeine / guaifenesin).
Iophen-C NR disease interactions
There are 16 disease interactions with Iophen-C NR (codeine / guaifenesin) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
QR code containing a link to this page
More about Iophen-C NR (codeine / guaifenesin)
- Iophen-C NR consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
